Bristol-Myers Squibb
BMY
#189
Rank
A$161.99 B
Marketcap
A$79.33
Share price
-1.56%
Change (1 day)
4.70%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): A$5.29

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is A$5.08. In 2025 the company made an earnings per share (EPS) of A$4.94 an increase over its 2024 EPS that were of A-$6.31.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$5.297.17%
2025A$4.94-178.28%
2024A-$6.31-213.92%
2023A$5.5430.2%
2022A$4.25-6.04%
2021A$4.53-179.29%
2020A-$5.71-281.37%
2019A$3.15-27.21%
2018A$4.32
2016A$3.81175.26%
2015A$1.38-19.83%
2014A$1.73-22.44%
2013A$2.2334.48%
2012A$1.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.47 145.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.02 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.87-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.93-42.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$40.27 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.66 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.65-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$13.34 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$5.08-0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$9.92 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK